Literature DB >> 12607719

Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants.

Irving Shen1, Carmen Giacomuzzi, Ross M Ungerleider.   

Abstract

The use of cardiopulmonary bypass is still necessary for the repair of many congenital cardiac defects. However, exposure to cardiopulmonary bypass can still lead to major morbidity and sometimes mortality, especially in neonates and infants, despite a perfect surgical repair. Various research-based strategies have been used to minimize some of the complications related to cardiopulmonary bypass, including the systemic inflammatory response, hemodilution, and transfusion requirement. This overview provides some of the strategies that we use in our practice in applying cardiopulmonary bypass in the repair of congenital cardiac defects in neonates and infants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607719     DOI: 10.1016/s0003-4975(02)04697-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Perfusionist strategies for blood conservation in pediatric cardiac surgery.

Authors:  Yves Durandy
Journal:  World J Cardiol       Date:  2010-02-26

2.  Transfusion-free cardiopulmonary bypass in Jehovah's Witness patients weighing less than 5 kg.

Authors:  Wolfgang Boettcher; Frank Merkle; Michael Huebler; Andreas Koster; Fritz Schulz; Michael Kopitz; Hermann Kuppe; Peter Lange; Roland Hetzer
Journal:  J Extra Corpor Technol       Date:  2005-09

3.  Are there benefits to a fresh whole blood vs. packed red blood cell cardiopulmonary bypass prime on outcomes in neonatal and pediatric cardiac surgery?

Authors:  Melinda S Valleley; Klayton W Buckley; Kylie M Hayes; Randall R Fortuna; Dale M Geiss; David W Holt
Journal:  J Extra Corpor Technol       Date:  2007-09

4.  Staged Versus Complete Repair in the Symptomatic Neonate With Tetralogy of Fallot.

Authors:  Jennifer Bailey; Okan U Elci; Christopher E Mascio; Laura Mercer-Rosa; Elizabeth Goldmuntz
Journal:  Ann Thorac Surg       Date:  2019-11-26       Impact factor: 4.330

5.  The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery.

Authors:  Chih-Yuan Lin; Jeffery H Shuhaiber; Hugo Loyola; Hua Liu; Pedro Del Nido; James A DiNardo; Frank A Pigula
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

6.  Neonatal congenital heart surgery: contemporary outcomes and risk profile.

Authors:  Ahmed Abdelrahman Elassal; Osman Osama Al-Radi; Ragab Shehata Debis; Zaher Faisal Zaher; Gaser Abdelmohsen Abdelmohsen; Mazen Shamsaldeen Faden; Nada Ahmed Noaman; Ahmed Ragab Elakaby; Mohamed Esam Abdelmotaleb; Ahmed Mostafa Abdulgawad; Mohamed Saleh Elhudairy; Abdulla Husain Jabbad; Ahmed Abdelaziz Ismail; Norah Bakheet Aljohani; Arwa Mohammed Alghamdi; Ahmed Mohamed Dohain
Journal:  J Cardiothorac Surg       Date:  2022-04-20       Impact factor: 1.522

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.